Jesse Damsker
Inventor
Stats
- 0 US patents issued
- 17 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 0 US Patents Issued
- 17 US Applications Filed
- 9 Total Citation Count
- Jul 22, 2024 Most Recent Filing
- Nov 29, 2012 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| Reveragen Biopharma, Inc | 1
1 | 2012
2016 |
Inventor Addresses
| Address | Duration |
|---|---|
| Alexandria, VA, US | Sep 10, 20 - Jan 21, 25 |
| Washington, DC, US | Jan 08, 15 - Oct 13, 20 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 13 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 4 |
| C07D: | HETEROCYCLIC COMPOUNDS | 3 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 12201639 | 2025 | Aqueous oral pharmaceutical suspension compositions | 0 |
| 2024/0376,071 | 2024 | ACID ADDITION SALTS, COMPOSITIONS, AND METHODS OF TREATING THEREOF | 0 |
| 2024/0307,411 | 2024 | NON-HORMONAL STEROID MODULATORS OF NF-KAPPA BETA FOR TREATMENT OF DISEASE | 0 |
| 2024/0299,416 | 2024 | TREATMENT OF NF-kB-MEDIATED DISEASE | 0 |
| 2024/0226,117 | 2024 | TREATMENT OF CONGENITAL ADRENAL HYPOPLASIA | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.